Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Accounts Payables (2020 - 2025)

Intelligent Bio Solutions has reported Accounts Payables over the past 5 years, most recently at $1.7 million for Q2 2024.

  • For Q2 2024, Accounts Payables fell 34.69% year-over-year to $1.7 million; the TTM value through Jun 2024 reached $1.7 million, down 34.69%, while the annual FY2024 figure was $1.7 million, 34.69% down from the prior year.
  • Accounts Payables for Q2 2024 was $1.7 million at Intelligent Bio Solutions, down from $2.1 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $3.6 million in Q3 2023 and troughed at $448886.0 in Q4 2021.
  • A 5-year average of $1.5 million and a median of $1.6 million in 2021 define the central range for Accounts Payables.
  • On a YoY basis, Accounts Payables climbed as much as 313.35% in 2022 and fell as far as 41.9% in 2022.
  • Year by year, Accounts Payables stood at $734825.0 in 2020, then tumbled by 38.91% to $448886.0 in 2021, then skyrocketed by 313.35% to $1.9 million in 2022, then decreased by 4.98% to $1.8 million in 2023, then decreased by 3.31% to $1.7 million in 2024.
  • Business Quant data shows Accounts Payables for INBS at $1.7 million in Q2 2024, $2.1 million in Q1 2024, and $1.8 million in Q4 2023.